#gene therapy pipeline

Discover 3 curated intelligence briefings related to this specific topic.

Recovery Costs Are Killing the Bio-Revolution
Science & Nature

Recovery Costs Are Killing the Bio-Revolution

The pharmaceutical industry has a blind spot. We celebrate the discovery of new molecules but ignore the brutal economics of downstream processing, where recovery costs and material instability turn laboratory breakthroughs into commercial failures.

Read Analysis
Hard Assets for Invisible Intelligence: The Global Race for Power and Precision
Science & Health

Hard Assets for Invisible Intelligence: The Global Race for Power and Precision

From a $1.3 billion energy play in South Korea to the US government's 2028 quantum deadline, the infrastructure for the next decade is being built now.

Read Analysis
Is the biological script finally being rewritten?
Science & Health

Is the biological script finally being rewritten?

Recent breakthroughs in June 2026 reveal a decisive move from managing chronic disease to active cellular restoration, scaling across 1,300 active gene therapy programs globally.

Read Analysis